Maimonides Research & Development Foundation

The Maimonides Research & Development Foundation is a subordinate supporting organization of Maimonides Medical Center, operating as its tax-exempt grantmaking and research-administration arm. It cannot act independently of the medical center's charitable mission and draws its governance from the hospital's board of trustees. This means investment returns ultimately cycle back into clinical operations, facility expansion, and medical research grants.

Investment decisions are governed by a board of trustees led by Chair Steven Eisenstadt, whose family founded both the foundation and the hospital. The board includes trustees with significant personal real estate holdings — Peter Rebenwurzel, Yehoshua Fruchthandler, and Avi Schron — all of whom participate in disclosed joint real estate ventures that overlap with the foundation's physical assets. The foundation does not publicly disclose an internal investment committee or outside CIO.

The foundation holds a concentrated portfolio of Brooklyn healthcare properties: the Maimonides Cancer Center, Maimonides Midwood Community Hospital, the Doctors' Pavilion, an employee housing portfolio, and administrative buildings on Fort Hamilton Parkway and Atlantic Avenue. These are operational assets, not passive holdings — their value is tied directly to the hospital's service volumes and the surrounding real estate market in Borough Park and Clinton Hill.

The foundation does not operate as a conventional endowment allocator. Instead of issuing RFPs or committing to external GPs, it invests almost exclusively in Brooklyn real estate adjacent to or directly supporting Maimonides Medical Center's clinical mission. Trustee co-investment vehicles — particularly those involving the Fruchthandler and Schron families — function as the primary sourcing mechanism for new projects. There is no disclosed allocation to venture capital, private equity funds, or hedge funds.

The foundation does co-invest, but exclusively with its own trustees and affiliated families rather than with arm's-length institutional partners. Disclosed joint real estate ventures with the Fruchthandler and Schron families operate alongside the foundation's wholly owned assets, creating a closed network that rewards participants who already serve on the hospital's board. The structure is closer to a family-backed real estate syndicate than to an endowment co-investment program open to outside LPs.

The foundation's capital base originates from the Eisenstadt family, who founded Maimonides Medical Center, and has since been supplemented by hospital operating surpluses, real estate appreciation, and donations from Brooklyn's Orthodox Jewish community. The disclosed joint ventures with trustee families suggest that intergenerational wealth from the Fruchthandler and Schron families also plays a role in capitalizing specific projects, though the foundation does not disclose contribution amounts.

The 2023 city-led plan to merge Kingsbrook Jewish Medical Center into the Maimonides system will likely increase the foundation's real estate holdings and require restructuring existing assets to accommodate the expanded clinical network. Trustee-governed investment vehicles tied to existing facilities — particularly the Fruchthandler and Schron joint ventures — may need to be restructured or diluted to accommodate new assets. No public disclosures detail the planned investment vehicle changes.